There is a rich literature available suggesting that SPIB promotes trans-activation of SPI1 to increase glycolytic gene expression and drive the glycolytic process, proliferation, and invasiveness of colon cancer cells [25]. Here, SPI1 is linked to malignant colon neoplasm.